ADA Scientific Sessions 2025 Abstract

Real-World Efficacy of Combined SGLT2i and GLP-1RA Therapy in Elderly Patients with Type 2 Diabetes and Obesity

By Anna Ferrulli, Pamela Senesi, Livio Luzi

Study in peopleInterventions

The paper

Anna Ferrulli, Pamela Senesi, Livio Luzi

Sesto San Giovanni (MI)

ADA Scientific Sessions 2025 Abstract, 13 Jun 2025

Presented at ADA Scientific Sessions 2025, poster 760-P

doi.org/10.2337/db25-760-p

Diabetes & Vascular Disease Research4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Clinical Journal of the American Society of Nephrology4 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes
Diabetes, Obesity & Metabolism4 Oct 2026
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Diabetes, Obesity & Metabolism8 Oct 2026
Diabetes drug class linked to slightly less frailty progression